Quote | Rallybio Corporation (NASDAQ:RLYB)
Last: | $1.545 |
---|---|
Change Percent: | 2.41% |
Open: | $1.62 |
Close: | $1.545 |
High: | $1.66 |
Low: | $1.48 |
Volume: | 133,564 |
Last Trade Date Time: | 06/14/2024 03:00:00 am |
News | Rallybio Corporation (NASDAQ:RLYB)
2024-05-31 07:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Morgan Stanley recently released its bullish take on the biotech space, driven by anticipated interest rate cuts and a surge in mergers and acquisitions (M&A) activity. The analyst firm...
2024-05-10 16:15:47 ET More on Rallybio Rallybio shares gain on investment from J&J for rare fetal condition treatment Seeking Alpha’s Quant Rating on Rallybio Read the full article on Seeking Alpha For further details see: Rallybio files to se...
Message Board Posts | Rallybio Corporation (NASDAQ:RLYB)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Rallybio Corporation Company Name:
RLYB Stock Symbol:
NASDAQ Market:
- On Track to Initiate RLYB212 Phase 2 Dose Confirmation Trial in Pregnant Women at Higher Risk of FNAIT in 2H 2024 - - $94.2 Million in Cash, Cash Equivalents, and Marketable Securities as of March 31, 2024; Provides Runway into Mid-2026 - Rallybio Corporation (Nasdaq: RLYB), a...
Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced that Steve Uden, M.D., Chief Executive Officer of Rallybio, will partici...